KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Income from Continuing Operations for 8 consecutive years, with 2332000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 124.32% to 2332000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 24124000.0 through Dec 2025, down 232.22% year-over-year, with the annual reading at 24158000.0 for FY2025, 232.41% down from the prior year.
  • Income from Continuing Operations hit 2332000.0 in Q4 2025 for Castle Biosciences, down from 501000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9590000.0 in Q4 2024 to a low of 29204000.0 in Q1 2023.
  • Historically, Income from Continuing Operations has averaged 8436300.0 across 5 years, with a median of 5592500.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 1039.38% in 2023 and later surged 471.71% in 2024.
  • Year by year, Income from Continuing Operations stood at 13381000.0 in 2021, then crashed by 54.08% to 20618000.0 in 2022, then skyrocketed by 87.49% to 2580000.0 in 2023, then soared by 471.71% to 9590000.0 in 2024, then tumbled by 124.32% to 2332000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CSTL at 2332000.0 in Q4 2025, 501000.0 in Q3 2025, and 4557000.0 in Q2 2025.